CCSD code B1220 – Fine needle aspiration of thyroid gland

Key takeaways

CCSD Code B1220 covers the procedure fee for fine needle aspiration of the thyroid gland, not the cytology report or the consultation.

Ultrasound guidance is not described in B1220, so check the CCSD schedule and the insurer for whether a separate imaging code applies.

CCSD lists B1220 and B1230 (core biopsy of thyroid gland) as an unacceptable combination, so the two cannot be claimed together.

Bupa, AXA Health and Vitality usually require prior authorisation before the procedure, while Aviva and Cigna UK decide case by case.

Pabau’s claims management software supports CCSD code entry, insurer-specific fee schedules and Healthcode submission for UK private practices.

CCSD Code B1220: definition and clinical scope

CCSD Code B1220 is the procedure code for fine needle aspiration of the thyroid gland in UK private healthcare billing. It pays the specialist’s fee for passing a fine-gauge needle into a thyroid nodule or mass, aspirating cells and preparing the specimen for cytology.

The laboratory’s fee for analysing the aspirate sits outside B1220, and so does the outpatient consultation. Ultrasound guidance is not described in the code, so check the CCSD schedule and the insurer for whether a separate imaging code applies. The chart below shows where each part of the encounter lands.

B1220 sits in the CCSD Schedule of Procedures, which UK private medical insurers such as Bupa, AXA Health, Vitality, Aviva, WPA and Cigna use. The full CCSD code list shows its neighbouring procedures. The CCSD Technical Guide (October 2025) sets out the business rules for applying these codes, including unacceptable combinations.

The fine needle aspiration procedure: what it involves

A thyroid FNA takes between five and fifteen minutes. Knowing the steps helps coders check that the documentation matches the procedure performed and supports B1220.

1. Patient positioning. The patient lies supine with the neck slightly extended to expose the thyroid region.
2. Skin preparation. The overlying skin is cleaned. Local anaesthetic is optional and depends on the operator’s practice.
3. Needle insertion. A fine-gauge needle (typically 23-25G) is introduced into the nodule, either freehand or under ultrasound guidance.
4. Aspiration passes. The needle is advanced with a to-and-fro motion while negative pressure is applied, collecting cellular material. Multiple passes may be made within the same sitting.
5. Specimen preparation. The aspirate is expelled onto glass slides for cytological smears, or placed in liquid-based cytology medium, then sent to the laboratory.
6. Post-procedure documentation. The operator records the nodule location, number of passes, specimen adequacy assessment, and any complications.

The procedure note generated at step six is the primary document supporting a B1220 claim. If it is absent or incomplete, insurers are likely to decline payment.

Clinical indications: when is CCSD Code B1220 appropriate?

B1220 is appropriate when a clinician performs fine needle aspiration to characterise a thyroid nodule or mass that warrants cytological evaluation. UK consultants generally follow the British Thyroid Association (BTA) guidelines. These grade nodules on ultrasound from U1 to U5 and recommend FNA for U3 to U5.

• A nodule graded U3 (indeterminate or equivocal) on ultrasound
• A nodule graded U4 (suspicious) or U5 (malignant), such as a solid hypoechoic nodule with irregular margins or microcalcifications
• A palpable thyroid mass in a patient with risk factors for thyroid malignancy (family history, prior radiation, RET proto-oncogene mutation)
• Suspected recurrence of thyroid cancer at a known post-operative site
• A multinodular goitre where one nodule has features disproportionate to the others

Size cut-offs such as 1 cm for high-suspicion nodules come from the US American Thyroid Association (ATA) 2015 scheme, not the BTA. Under ATA 2015, intermediate-suspicion nodules qualify at 1 cm, low-suspicion at 1.5 cm and spongiform nodules at 2 cm.

The claim file should link the indication to the U grade and nodule features on the ultrasound report. A U2 nodule, such as a purely cystic one, is unlikely to be covered, because the BTA does not routinely recommend aspirating benign-appearing nodules.

Ultrasound guidance and B1220: what sits outside the code

B1220 describes the aspiration only. Ultrasound guidance is not described in B1220, so check the CCSD schedule and the insurer for whether a separate imaging code applies.

Where a separate imaging code does apply, confirm it against the current CCSD Schedule of Procedures, as codes in this area are reviewed periodically. The Bupa code search tool lets practitioners check CCSD procedure codes against Bupa’s agreed fees before submission.

Related thyroid codes: B1230 and B1250

B1220 sits beside two other CCSD thyroid codes. The one that causes claim disputes is B1230, because CCSD lists B1220 and B1230 as an unacceptable combination. They cannot be billed together.

B1250 covers revision surgery, so it does not compete with B1220 on the same claim. Verify each descriptor against the current CCSD Schedule of Procedures before use, as the schedule is revised periodically.

Documentation requirements for a valid B1220 claim

A B1220 claim is only as strong as the procedure note supporting it. Insurers auditing this code will request the clinical record, and a claim without the elements below is vulnerable to denial or clawback. Keeping them in electronic patient records means they can be produced on demand.

• Procedure note: operator name, date, nodule location (e.g. right lobe lower pole), needle gauge, number of passes, specimen preparation (smear or liquid-based) and adequacy assessment
• Clinical indication: documented nodule size and ultrasound features (or palpation findings without imaging), including the BTA U grade that triggered the procedure
• Consent record: signed informed consent, including discussion of a possible non-diagnostic result and the need for repeat aspiration
• Ultrasound report: if imaging guidance was used, the radiologist’s or operator’s report confirming the nodule targeted, which also supports any separate imaging claim
• Cytology request form: the laboratory requisition sent with the specimen, confirming what was requested and by whom
• Operator details: confirmation that the insurer recognises the performing clinician for this procedure, as some insurers restrict payment to specific specialties

UK GDPR requires patient records supporting private healthcare claims to be kept securely. In Pabau’s digital clinical forms, consent and procedure notes are captured in a structured, audit-ready format. Staff then spend less time retrieving them when an insurer asks for evidence. Check that your retention periods cover each insurer’s audit window.

Payer requirements: prior authorisation and insurer rules

Most major UK private medical insurers require prior authorisation (pre-auth) before a thyroid FNA is performed. Proceeding without it is a common reason for a B1220 claim to be declined in full. Our guide to Bupa CCSD codes covers Bupa-specific submission rules.

Pre-auth rules change without notice. Always confirm the current requirement directly through each insurer’s provider portal before the procedure date. The authorisation number must appear on every invoice submitted for B1220.

Common claim denial reasons for B1220 and how to avoid them

Denials for B1220 cluster around a small set of avoidable errors. The table below maps each root cause to the corrective action that prevents recurrence.

Billing multiple aspirations in one session

B1220 covers fine needle aspiration of the thyroid gland as a procedure and sets no limit on the number of passes within one aspiration episode. Multiple passes into a single nodule to obtain an adequate specimen are standard technique and do not generate a separate B1220 claim. The question arises when a clinician aspirates two anatomically distinct nodules in the same sitting.

When nodules in different lobes are aspirated in the same appointment, a separate claim for each nodule may be clinically justified. However, most UK private medical insurers treat duplicate B1220 submissions on the same date as a potential billing error unless the procedure note explicitly documents:

• The distinct location of each nodule targeted (e.g. right lobe, 12mm nodule; left lobe, 18mm nodule)
• The clinical rationale for aspirating more than one nodule in the same session
• Separate specimen preparation records for each aspirate

Without this documentation, insurers are likely to pay only one unit and query the second. If you expect to bill B1220 twice on the same date, contact the insurer’s provider line before the procedure. Some insurers pre-authorise each nodule individually. Rules vary by insurer, so verifying in advance is the only reliable safeguard.

Coding the cytology report: associated pathology codes

The cytological analysis of the FNA aspirate is a separate professional service performed by a pathologist or cytopathologist. It is not included in B1220 and is billed separately. In practice, the laboratory or pathology department invoices for the report, and the operating consultant submits B1220 on their own invoice.

UK thyroid cytology is reported in the BTA and Royal College of Pathologists (RCPath) Thy categories, from Thy1 (non-diagnostic) to Thy5 (malignant). The Bethesda system is the US equivalent. The Thy category drives clinical management but does not change the procedure code, so B1220 applies whether the result is Thy1 or Thy5.

A Thy1 result often leads to a repeat FNA. CCSD has no separate repeat-FNA code, so the second aspiration is billed as B1220 again, subject to insurer rules.

Where the operating consultant is also the cytopathologist (unusual in UK private practice), the procedural and laboratory components should still be claimed separately. Confirm the correct pathology code with the laboratory and the insurer, as cytology billing is revised periodically.

How to record CCSD Code B1220 in practice management software

Accurate code entry and fee mapping in your practice management system stop the most common administrative errors before a claim reaches the insurer. The steps below apply to any UK private practice using software that supports CCSD billing. Pabau’s private practice claims software supports CCSD code entry, insurer-specific fee schedules and Healthcode submission.

1. Add B1220 to your service list. Enter the code, its official descriptor (“Fine needle aspiration of thyroid gland”), and any insurer-specific fee variants you bill under.
2. Set insurer-specific fee schedules. Each PMI agrees its own fee for B1220, which may differ from the CCSD schedule list price. Enter each insurer’s agreed rate separately so invoices are generated at the correct amount per payer.
3. Attach the pre-authorisation number at booking. Record the authorisation reference when the B1220 appointment is booked. This stops the procedure going ahead before pre-auth is secured.
4. Link the procedure note template to the code. Associate a structured procedure note template with B1220 so clinicians complete all mandatory fields (nodule location, passes, specimen type, adequacy) at the point of care.
5. Review and submit the claim. Before submission, check the invoice carries the authorisation number, the correct code, the date of service and the clinician’s recognition number. A pre-submission checklist catches missing fields before the claim leaves the practice.

When the booking, consent form, procedure note and invoice live in separate places, the authorisation number gets retyped at each stage. In Pabau they sit on one patient record, so staff check each B1220 claim in a single file. Comparing tools? Start with our guide to UK medical billing software.

Manage CCSD billing and insurer claims in one place

Pabau supports CCSD code entry, insurer-specific fee schedules and Healthcode submission, with procedure notes and consent stored on the patient record. See how it fits your endocrinology or surgical practice.

Book a demo

Conclusion

B1220 is narrowly scoped, which makes it a straightforward CCSD code to get paid on first submission. Most avoidable B1220 denials start before the procedure, with a missing pre-auth or an indication the ultrasound report does not back up.

So put the effort upstream. Secure the authorisation at booking and record the U grade in the note. Settle on B1220 or B1230 before the needle goes in, because the two cannot share a claim.

If your team retypes the same authorisation number into three systems, that is where the next denial will come from. Book a demo to see how Pabau keeps B1220 bookings, procedure notes and Healthcode claims on one record.

Continue your research

Need the full Bupa CCSD code reference? Bupa CCSD codes and fee schedule covers Bupa’s procedure codes, submission rules and fee structure for UK private practice.

Taking a tissue core instead of cells? CCSD code B1230: core biopsy of thyroid gland explains when core biopsy applies and why it cannot share a claim with B1220.

Is the next step a hemithyroidectomy? CCSD code B0860: partial thyroidectomy covers the billing rules for the surgery that often follows an indeterminate FNA.

Choosing software for CCSD billing? Best medical billing software in the UK compares the platforms UK private practices use to code and submit insurer claims.

Frequently asked questions